• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

A Number of Positive Factors Are Expected to Help OTC Healthcare in Ireland

Posted on: Tuesday, 7 March 2006, 06:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c34052) has announced the addition of Eye Care in Ireland to their offering.

A number of positive factors are expected to help OTC healthcare in Ireland register total growth of 31% in constant value terms over the forecast period. A growing number of older people in the population, an increased tendency towards self-medication, a rethink of reimbursements and longer working hours will result in rising demand for products in all OTC healthcare sectors. The entry of private label products and a larger distribution share for non-specialist channels will lead to a reduction in the unit prices of some products, which could limit the pace of constant value growth overall between 2004 and 2009.

This "Eye Care in Ireland" report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage includes standard eye care and allergy eye care. Data coverage includes market sizes (historic and forecasts), company shares, brand shares.

Why buy this report?

-- Get a detailed picture of the eye care industry

-- Pinpoint growth sectors and trends and identify factors driving change

-- Understand the competitive environment, the market's major players and leading brands

-- Use five-year forecasts to assess how the market is predicted to develop

Companies Mentioned Include:

-- GlaxoSmithKline (Ireland) Ltd

-- Pfizer Ireland Pharmaceuticals

-- Wyeth Consumer Healthcare Ireland Ltd

-- Crookes Healthcare Ltd

-- Reckitt Benckiser Ireland Ltd

-- Seven Seas Ireland Ltd

-- Roche Consumer Healthcare

-- SSL International Plc

-- Novartis Ireland Ltd

-- Beeline Healthcare Ltd

-- Bayer Ltd

-- Procter & Gamble (Manufacturing) Ireland Ltd

-- Unigreg Ltd

-- Stiefel Laboratories (Ireland) Ltd

-- Janssen-Cilag Ltd

-- DDD Group, The

-- Sona Healthcare Ltd

-- Johnson & Johnson (Ireland) Ltd

-- Windsor Healthcare Ltd

-- Smith & Nephew Ltd

-- Monmouth Pharmaceuticals Ltd

-- Aventis Pharma Ltd

-- Lane Health Products Ltd, GR

-- Adams Confectionery

-- Nutricare Ltd

-- Quest Vitamins Ltd

-- Tosara Products Ltd

-- Vitabiotics Ltd

-- Cadbury Ireland Ltd

-- Ovelle Ltd

-- Quinoderm Ltd

-- Pinewood Healthcare Group

-- English Grains Ltd

-- Mentholatum Co Ltd, The

-- Masterfoods Ireland Ltd

-- Chefaro Ireland Ltd

-- Lifeplan Products Ltd

-- Antigen Pharmaceuticals Ltd

-- Ransom Consumer Healthcare

-- Hoechst Ireland Ltd

-- Fleming Medical Ltd

-- Schering-Plough (Ireland) Co

-- Clonmel Healthcare Ltd

-- 3M Ireland Ltd

-- Prestige Brands International Inc

-- Aventis Ireland Ltd

-- Ricesteele Healthcare Ltd

-- Esi Optima Healthcare

-- Rowa Pharmaceuticals

-- Lab Ltd

-- Abbott Laboratories (Ireland) Ltd

-- Pharmacia Ireland Ltd

-- Peter Black Healthcare Ltd

For more information visit http://www.researchandmarkets.com/reports/c34052

Source: Business Wire

More News in this Category